Strategic R&D A&Z has a robust R&D footprint with dedicated research laboratories and an integrated AiPing contract development and manufacturing operation, presenting opportunities to upsell development partnerships, custom formulations, and scale-up manufacturing for pharma and nutraceutical products.

Global Brand Strength Flagship D-Cal and MFIT Supps lines are recognized in multiple markets including China, indicating potential for international expansion collaborations, co-marketing arrangements, and distribution partnerships to leverage established brand trust.

N95 Manufacturing Recent state-grant support for N95 respirator production signals capability and interest in rapid-response manufacturing, offering a doorway to contract manufacturing opportunities in medical PPE and related sterile product lines.

Sustainable Growth Revenue scale in the hundreds of millions with a broad employee base and ongoing expansion of facilities suggests capacity for additional private-label manufacturing, white-label exits, and extended service offerings to existing clients.

Full-Service Ops End-to-end production from product development to launch under AiPing provides a compelling platform for end-to-end CDMO partnerships, enabling cross-sell of formulation, regulatory support, and manufacturing services to pharmaceutical and nutraceutical clients.